Dr. Ana Aleyda Morales, MD

Dr. Morales practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Morales' NPI, 1023305760, was assigned on July 1, 2011. Dr. Morales holds Connecticut license 062131.

Dr. Morales' primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Morales also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Morales' primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morales practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Morales' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Morales is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Morales' licenses on file in 3 states: Connecticut, New Hampshire and Ohio.

CMS data shows 1,292 Medicare services from Dr. Morales across 15 procedure codes in 2024, for 319 Medicare patients. Medicare paid $65,220 for them.

CMS counts 319 Medicare patients who saw Dr. Morales in 2024. The largest group is 65 to 74, with 167 patients. 72% of them have high blood pressure, and 67% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morales' median patient age at 73, with 65% women.

In 2024, Dr. Morales wrote 1,129 Medicare Part D claims for 338 patients. 41% of them were for generic drugs. CMS names the drug for 1,056 of them, across 15 drugs with 11 or more claims each, at $258,305 in total drug cost. In 2023, CMS named 756 claims across 12 drugs.

Dr. Morales accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of cataract surgery by Dr. Morales, more than 58% of the clinicians it reports for that procedure.

CMS Open Payments shows 32 general payments to Dr. Morales from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 82% of the total. TissueTech, Inc. paid the most, $871.